ALPS Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$403K Buy
5,152
+62
+1% +$4.85K ﹤0.01% 755
2025
Q1
$369K Buy
+5,090
New +$369K ﹤0.01% 667
2024
Q1
Sell
-4,211
Closed -$321K 1007
2023
Q4
$321K Sell
4,211
-293
-7% -$22.3K ﹤0.01% 820
2023
Q3
$312K Buy
4,504
+234
+5% +$16.2K ﹤0.01% 856
2023
Q2
$403K Buy
4,270
+30
+0.7% +$2.83K ﹤0.01% 659
2023
Q1
$351K Buy
+4,240
New +$351K ﹤0.01% 679
2022
Q3
Sell
-3,248
Closed -$309K 1102
2022
Q2
$309K Sell
3,248
-34
-1% -$3.24K ﹤0.01% 776
2022
Q1
$386K Buy
3,282
+240
+8% +$28.2K ﹤0.01% 504
2021
Q4
$394K Buy
3,042
+37
+1% +$4.79K ﹤0.01% 681
2021
Q3
$340K Sell
3,005
-1,169
-28% -$132K ﹤0.01% 793
2021
Q2
$432K Hold
4,174
﹤0.01% 548
2021
Q1
$349K Buy
+4,174
New +$349K ﹤0.01% 587
2020
Q3
Sell
-3,446
Closed -$238K 860
2020
Q2
$238K Sell
3,446
-379
-10% -$26.2K ﹤0.01% 688
2020
Q1
$240K Sell
3,825
-957
-20% -$60K ﹤0.01% 607
2019
Q4
$372K Sell
4,782
-207
-4% -$16.1K ﹤0.01% 646
2019
Q3
$366K Sell
4,989
-14,124
-74% -$1.04M ﹤0.01% 579
2019
Q2
$1.18M Sell
19,113
-2,304
-11% -$142K 0.01% 294
2019
Q1
$1.37M Sell
21,417
-1,326
-6% -$84.6K 0.01% 269
2018
Q4
$1.16M Buy
22,743
+33
+0.1% +$1.69K 0.01% 277
2018
Q3
$1.32M Buy
+22,710
New +$1.32M 0.01% 312
2018
Q1
Sell
-12,312
Closed -$463K 913
2017
Q4
$463K Hold
12,312
﹤0.01% 621
2017
Q3
$449K Sell
12,312
-2,994
-20% -$109K ﹤0.01% 667
2017
Q2
$603K Buy
15,306
+42
+0.3% +$1.66K ﹤0.01% 358
2017
Q1
$479K Buy
15,264
+4,593
+43% +$144K ﹤0.01% 524
2016
Q4
$333K Sell
10,671
-195
-2% -$6.09K ﹤0.01% 659
2016
Q3
$437K Sell
10,866
-2,964
-21% -$119K ﹤0.01% 373
2016
Q2
$460K Sell
13,830
-1,008
-7% -$33.5K ﹤0.01% 314
2016
Q1
$436K Buy
+14,838
New +$436K ﹤0.01% 454
2015
Q3
Sell
-21,390
Closed -$508K 699
2015
Q2
$508K Buy
21,390
+336
+2% +$7.98K ﹤0.01% 489
2015
Q1
$500K Sell
21,054
-9,564
-31% -$227K ﹤0.01% 574
2014
Q4
$650K Sell
30,618
-4,104
-12% -$87.1K 0.01% 216
2014
Q3
$591K Sell
34,722
-13,650
-28% -$232K ﹤0.01% 317
2014
Q2
$692K Buy
48,372
+1,248
+3% +$17.9K 0.01% 213
2014
Q1
$583K Buy
47,124
+5,592
+13% +$69.2K 0.01% 346
2013
Q4
$451K Buy
41,532
+20,160
+94% +$219K ﹤0.01% 478
2013
Q3
$248K Buy
+21,372
New +$248K ﹤0.01% 467